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Background: Advanced structure-activity relationship (SAR) modeling can be used as an alternative tool for
identification of skin sensitizers and in improvement of the medical diagnosis and more effective practical measures
to reduce the causative chemical exposures. It can also circumvent ethical concern of using animals in toxicological
tests, and reduce time and cost. Compounds with aniline or phenol moieties represent two large classes of
frequently skin sensitizing chemicals but exhibiting very variable, and difficult to predict, potency. The mechanisms
of action are not well-understood.
Methods: A group of mechanistically hard-to-be-classified aniline and phenol chemicals were collected. An in silico
model was established by statistical analysis of quantum descriptors for the determination of the relationship
between their chemical structures and skin sensitization potential. The sensitization mechanisms were investigated
based on the features of the established model. Then the model was utilized to analyze a subset of FDA approved
drugs containing aniline and/or phenol groups for prediction of their skin sensitization potential.
Results and discussion: A linear discriminant model using the energy of the highest occupied molecular orbital
(ϵHOMO) as the descriptor yielded high prediction accuracy. The contribution of ϵHOMO as a major determinant may
suggest that autoxidation or free radical binding could be involved. The model was further applied to predict
allergic potential of a subset of FDA approved drugs containing aniline and/or phenol moiety. The predictions
imply that similar mechanisms (autoxidation or free radical binding) may also play a role in the skin sensitization
caused by these drugs.
Conclusions: An accurate and simple quantum mechanistic model has been developed to predict the skin
sensitization potential of mechanistically hard-to-be-classified aniline and phenol chemicals. The model could be
useful for the skin sensitization potential predictions of a subset of FDA approved drugs.
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Skin sensitization related dermatitis and rash represents
the most common manifestation of chemical immunotoxi-
city in humans, which results in a cost estimated $1 billion
annually due to lost work, reduced productivity, medical
care, and disability payments in USA [1,2]. In addition, as
part of the regulatory review process, an increase in the in-
cidence of skin allergies and hypersensitivity-related ad-
verse events associated with the use of FDA regulated
products or approved drugs has been observed, suggesting
a safety gap between premarket review and the post mar-
ket surveillance [2].
Common testing methods to assess skin sensitization
potential of materials include: (1) guinea pig maximization
test (GPMT); (2) murine-based local lymph node assay
(LLNA). In GPMT tests, hazard identification is done by
visual observations of erythema and edema reactions,
which are subjective, are difficult to differentiate between
contact allergens and strong irritants, and is time consum-
ing [3]. The LLNA is recommended by international regu-
latory agencies; however, inconsistencies between LLNA
and clinical observations have been documented [4]. Con-
sidering the existence of vast compounds around today, de-
veloping rapid and effective methods for chemical sensitizer
identification/risk assessment is still a challenge [2].
In silico approaches are an attractive alternative to
animal testing through analyzing the structural features
of sensitizers/non-sensitizers to derive predictive rules
or models [5]. The risks of thousands of commercially
available chemicals could be assessed in a cost effective
manner. Among these approaches, mechanism based
rules, which investigate the structural characteristics of
sensitizers, are promising [6].
Historically, the first study of chemical reactivity and
skin sensitization was reported in 1936 [7]. A mechan-
ism of small organic molecules to form an immunogenic
complex by reacting with macromolecules (proteins or
others) in the skin to cause sensitization was postulated.
Currently, a more plausible mechanism reported in-
volves a formation of covalent bonding between electro-
philic allergens and nucleophilic moieties of amino acids
from skin proteins (usually side chains) [8]. Such amino
acids include cysteine thiol (mainly) and lysine (amino),
and to a lesser extent arginine, histidine, methionine and
tyrosine [9]. Based on the well-established principles
of mechanistic organic chemistry, the skin sensitization
potential of a chemical in many cases was predicted by
its reactivity with these residues [9,10]. However, some
compounds need to be activated via either autoxidation
outside the skin (prehaptens) or bioactivation inside the
skin (prohaptens) to be able to form immunogenic com-
plexes with skin proteins [11].
Structure-activity relationship (SAR) studies of skin
sensitization potential have been successfully carried outfor epoxyaldehydes [12], enone [13], halogenated aro-
matics [14], benzaldehydes [15], dienes [16], oximes
[17], aldehydes [18] and epoxides [19]. Aniline/aromatic
amine and/or phenol derivatives are two large classes of
frequently sensitizing chemicals. Quite a few pilot studies
have been conducted [20-23]. Roberts et al. specifically
investigated the sensitization mechanisms of diamino-
benzenes or dihydroxylbenzenes [24]. However, the pre-
dictability of the skin sensitization potential for these two
classes of chemicals is unsatisfactory [6,25]. Further ex-
ploration of novel sensitization mechanisms will be in-
formative for constructing better SAR models/rules. In
addition, aniline and phenol moieties that are often
present in approved drugs can also cause skin sensitiza-
tion. For example, contact dermatitis occurs in one indi-
vidual following prolonged subcutaneous infusion of
hydromorphone [26], a cancer pain treatment agent which
contains one phenol moiety.
Drug-induced skin reactions may be associated with
several biological mechanisms, but in many cases the
precise mechanism is unclear [27]. It is well-known that
Type IV allergic reaction induced by many chemicals
and drugs is a T-cell mediated delay type hypersensitivity
which can cause skin sensitization/dermatitis [27].
In this study, we intended to establish an in silico
model for a class of mechanistically hard-to-classify ani-
lines and phenols to study the relationship between their
chemical reactivity and biological allergic response. We
then investigated sensitization mechanisms of action as-
sociated with these compounds based on the features of
this model. The model was further utilized to analyze a
subset of FDA approved drugs containing aniline and/or
phenol groups in skin sensitization potential. The pre-
dicted skin sensitization potential for these drugs was




A data set of 63 chemicals, including 30 anilines and
33 phenols, was collected from published literature
[11,23,28-36]. Chemicals with well-known allergic mecha-
nisms, i.e. Michael acceptors (MA), SN2 electrophiles,
SNAr electrophiles, Schiff base formers, and acylation
agents, were excluded from the data set. For example,
pentachlorophenol (CAS: 87-86-5) belongs to SNAr elec-
trophiles; benzyl salicylate (CAS: 118-58-1) and 3,3′,4′,5-
tetrachlorosalicylanilide (CAS: 1154-59-2) are acylation
agents. In addition, chemicals having two OH and NH2
substituents at aromatic rings were also excluded from the
data set because these compounds are known to easily
form a benzoquinone (a Michael acceptor) or a nitrogen
analogue of benzoquinone (also a Michael acceptor) [24].
Finally, a list of 30 chemicals was obtained (Table 1). They
Table 1 Summary of the ϵHOMO, predicted values of the 30 chemicals and their experimentally determined data
[11,23,28-36]
ID Cas # Name Sensitizer EC3 Ref. ϵHOMO (hartree) P
1 101-80-4 4,4-diaminodiphenylether Y 30 −0.262 1.0694
2 106-47-8 4-Chloroaniline Y 6.5 33,35 −0.289 0.6563
3 150-13-0 4-Aminobenzoic acid N 31 −0.306 0.3962
4 369-36-8 2-Fluoro-5-nitroaniline N 34 −0.325 0.1055
5 538-41-0 4,4-diaminoazobenzene Y 30 −0.258 1.1306
6 62-53-3 Aniline Y 89 31,36 −0.286 0.7022
7 79456-26-1 3-Chloro-5-(trifluoromethyl)-2-pyridinamine N 23 −0.326 0.0902
8 2050-14-8 2,2′-Azodiphenol Y 27.9 34 −0.294 0.5798
9 55845-90-4 (N-Benzyl-N-ethylamino)-3′-hydroxyacetophenone hydrochloride N 23 −0.316 0.2432
10 69-72-7 Salicylic acid N 31 −0.343 −0.1699
11 90-15-3 1-Naphthol Y 1.3 11,29.33 −0.274 0.8858
12 94-13-3 Propylparaben N 11 −0.329 0.0443
13 97-54-1 Isoeugenol Y 3.5 31,33,32 −0.277 0.8399
14 99-96-7 4-Hydrobenzoic acid N 11 −0.341 −0.1393
15 186743-26-0 3-Methyleugenol Y 32 33,36 −0.294 0.5798
16 101-77-9* 4,4-diaminodiphenylmethane Y 30 −0.266 1.0082
17 121-57-3* Sulphanilic acid N 11 −0.322 0.1514
18 537-65-5* 4,4-diaminodiphenylamine Y 30 −0.243 1.3601
19 60-09-3* 4-aminophenylazobenzene Y 30 −0.276 0.8552
20 63-74-1* Sulfanilamide N 11 −0.307 0.3809
21 94-09-7* Benzocaine N 33 −0.303 0.4421
22 15128-82-2* 3-Hydroxy-2-nitropyridine N 31 −0.362 −0.4606
23 2785-87-7* Dihydroeugenol Y 12.45 11,29,32 −0.288 0.6716
24 619-14-7* 3-Hydroxy-4-nitrobenzoic acid N 31 −0.371 −0.5983
25 80-05-7* bisphenol A Y 30 −0.287 0.6869
26 93-51-6* 2-Methoxy-4-methyl-phenol Y 5.8 11,29,32 −0.288 0.6716
27 97-53-0* Eugenol Y 13.95 31,32,33 −0.296 0.5492
28 99-76-3* Methyl 4-hydroxybenzoate N 11 −0.329 0.0443
29 119-36-8* Methyl salicylate N 28 −0.326 0.0902
30 831-82-3* 4-Phenoxyphenol Y 33 −0.293 0.5951
*Test set.
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compounds because they can’t be classified into any of the
abovementioned five categories. These compounds were
then randomly split into a training set of 15 compounds
and a test set of 15 compounds. As shown in Table 1, the
training set includes 7 anilines and 8 phenols, while the
test set includes 6 anilines and 9 phenols. The detailed in-
formation including initial screening of the 63 selected
chemicals is available as Additional file 1.
Quantum mechanics calculations
All chemical optimization and subsequent orbital
analysis were performed by using the Gaussian 03 suite
of programs [37]. Chemicals were optimized using theAM1 Hamiltonian with the default optimization criteria
[38,39]. Calculations of the frontier molecular orbital,
charge distribution and other quantum properties were
carried out by using the 6-31Gd basis set. The quantum
descriptors used in this study include the energies of the
highest occupied molecular orbital (ϵHOMO), the lowest
unoccupied molecular orbital (ϵLUMO), the second lowest
unoccupied molecular orbital (ϵLUMO+1), the second hig-
hest occupied molecular orbital (ϵHOMO-1), the Mulliken
atomic charges of the most negative (Qmin) and most
positive atoms (Qmax), the Mulliken atomic charges of
the N atom (QN) in anilines or O atom (QO) in phenols,
the average of the absolute values of the charges on all
atoms (Qm), and molecular dipole moment (μ). The
Figure 1 Correlation of skin sensitization potential of anilines
and phenols in the training set between experimental
allergenicity categories and predicted values from the model
built with quantum mechanistic properties. Experimental
allergenicity categories: 1 for sensitizer and 0 for non-sensitizer
respectively; Predicted Value (P) = 15.30 *ϵHOMO + 5.08. A compound
with a P greater than 0.50 is predicted as a sensitizer; otherwise, it is
predicted as a non-sensitizer.
Figure 2 Correlation of skin sensitization potential of anilines
and phenols in the test set between experimental allergenicity
categories and predicted values from the model built with
quantum mechanistic properties. Experimental allergenicity
categories: 1 for sensitizer and 0 for non-sensitizer respectively;
Predicted Value (P) = 15.30 *ϵHOMO + 5.08. A compound with the
P greater than 0.50 is predicted as a sensitizer; otherwise, it is predicted
as a non-sensitizer.
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GaussView application within Gaussian 03. All struc-
tures were either drawn or converted from SMILES
(Simplified molecular-input line-entry system) strings,
using Chembiodraw Ultra V12.0 (PerkinElmer Informat-
ics Desktop Software).
Statistical analysis
The skin sensitization potency of a compound was sym-
bolized by 1 (Yes) and 0 (No). The values of each quantum
descriptor were linearly normalized to the same range (0
to 1), stepwise linear regressions between the quantum
properties and experimental outputs of the training set
were performed by the statistical package of R program
version 3.0.0 [40]. The properties with lower weighting
factors were abandoned in the second step of linear
regression.
Results and discussion
The compounds with aniline and/or phenol moieties can
be classified into a single subclass for consideration of
skin sensitizers. However, not all of the compounds pos-
sessing aniline or phenol groups are sensitizers, suggest-
ing some compounds can form covalent bonds with skin
proteins whereas others cannot. In this study, the sen-
sitization potential of anilines and phenols were modeled
using quantum mechanical descriptors.
Modeling the skin sensitization potential by quantum
properties of anilines and phenols
The coefficient constant of ϵHOMO was determined as
the highest weighting factor based on the results of lin-
ear regression analysis. The skin sensitization potential
of anilines and phenols can be formulated as:
Predicted Value Pð Þ ¼ 15:30  ∈HOMO Hartreeð Þ
þ 5:08 1ð Þ ð1Þ
The median of the symbolized skin sensitization po-
tency, 0.50, was considered as the threshold for predic-
tion of sensitizers and non-sensitizers. An aniline or
phenol is predicted as a sensitizer if P is greater than
0.50, and as a non-sensitizer if P is below 0.5. With a
threshold of P =0.50, Equation 1 implies that a chemical
within the applicability domain is predicted to be a skin
sensitizer if the HOMO energy is greater than −0.30
Hartree ((0.5-5.08)/15.30 = −0.299 ≈ −0.30). The experi-
mental allergenicity categories (sensitizer or non-sensitizer)
and predicted results of the training set are shown in
Figure 1, where red-open circle dots indicate well-
known sensitizers at 1 and non-sensitizers at 0, respect-
ively. The blue-solid-diamond dots indicate the predicted
values. All of the training compounds were correctly pre-
dicted by Formula 1. The same model was applied to thetest set. Interestingly, all test compounds were correctly
predicted (Figure 2). The total prediction accuracy of
chemicals in training and test sets was 100% (30/30). The
model shows very high accuracy and only depends on the
value of ϵHOMO, suggesting that ϵHOMO is a key factor for
the assessment of skin sensitization potential of those anil-
ine and phenol containing compounds.
The linear relationship between the predicted values
and ϵHOMO also suggests that a chemical with higher
predicted value implies a higher reactivity for oxidation
consequently resulting in higher skin sensitization po-
tential. The LLNA data as a quantitative endpoint, posed
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potency. The EC3 values (effective concentration for a
three-fold proliferation of lymph node cells) from the re-
ported LLNA experiments of most allergen phenols were
also collected as shown in Table 1. Weak sensitizers with
higher EC3 values (meaning lower sensitization poten-
tial) have smaller P values. For example, P values of five
weak sensitizers with100 > EC3 > 10 i.e., eugenol (CAS:
97-53-0, EC3 = 13.95), Dihydroeugenol (CAS: 2785-87-7,
EC3 = 12.45), 2,2’-azodiphenol (CAS: 2050-14-8, EC3 =
27.90), 3-methyleugenol (CAS: 186743-26-0,EC3 = 32),
and aniline (CAS: 62-53-3, EC3 = 89) were 0.549, 0.672,
0.580, 0.580, and 0.702, respectively. On the other hand,
two moderate sensitizers, 2-Methoxy-4-methyl-phenol
(CAS: 93-51-6, EC3 = 5.8), 4-Chloroaniline (CAS: 106-
47-8, EC3 = 6.5), have a slightly higher P value 0.672,
0.656, respectively. Another two moderate sensitizers
with smaller EC3 value, isoeugenol (CAS: 97-54-1, EC3 =
3.5) and 1-naphthol (CAS: 90-15-3, EC3 = 1.3) have
greater P values, 0.840 and 0.886, respectively. For most
chemicals, their -logEC3 values correlate with P values
quite well, but for aniline, its –logEC3 value is much less
potent than its P value predicted. This may indicate that
the initial oxidation of aniline, which is quite fast, is not in
this case the rate-determining step for protein haptena-
tion. The analysis of the relationship between EC3 and
ϵHOMO for these nine chemicals was reported in the
Additional file 1.
Possible reaction mechanisms of aromatic anilines and
phenols
Occurrence of electrophilic–nucleophilic reactions be-
tween chemical and skin proteins is a primary reason of
chemical induced skin sensitization [8]. Most chemicals
with high skin sensitization potential can be classified as
Michael acceptors (MA), SN2 electrophiles, SNAr elec-
trophiles, Schiff base formers, or acylation agents. The
reaction mechanisms of anilines and phenols, however,
are poorly understood and very few of them can be clas-
sified into the aforementioned five categories. One pro-
posed mechanism is that sensitization occurs via oxygen
attack ortho to an amino group or via oxidative quinone-
methide formation [25,41]. For example, Roberts et al.
reported the mechanistic chemistry of aromatic diamino-,
dihydroxy-, and amino-hydroxy compounds [24] where
two parallel chemical mechanisms were described as the
most possible processes: oxidation to electrophilic (protein
reactive) quinones, quinone imines, or quinone di-imines
or formation of protein reactive free radicals. These mech-
anisms, unfortunately, are not applicable to the all single
NH/OH substituted anilines and phenols. For instance,
aniline and 4-butylaniline are sensitizers whereas 4-
aminobenzoic acid, 4-aminobenzenesulfonamide, and 4-
aminobenzenesulfonic acid are non-sensitizers. Beside thesolubility effects and the formation of ions/zwitterions, the
reactivity variety of chemical entities by substituent effects
play an important role in reducing dermal penetration and
immunogenicity of protein conjugates.
By analyzing the relationship between quantum prop-
erties and chemical reactivity, we successfully modeled
the skin sensitization potential of two groups of chemicals
(aromatic anilines and phenols) with a single coefficient of
ϵHOMO, while the energy of the lowest unoccupied mo-
lecular orbital (ϵLUMO), considered as the critical factor
for most electrophilic reactions [8,11], was poorly corre-
lated with sensitization potential. These results suggest
the skin sensitization mechanism of those compounds
may result from several steps but not a directly electro-
philic reaction.
The ϵHOMO dependent results implied that a process
of losing electron may be involved in the activation of
those sensitizers. Those compounds may be activated via
an autoxidation mechanism to further interact with skin
proteins as prehaptens. In addition, the mechanisms
where these chemicals directly react with free radical of
skin proteins also should be considered [42]. In the
present study, we proposed that two potential pathways
could lead these compounds to cause skin sensitization
as shown in Scheme 1 [42]. In the first pathway
(Scheme 1a), an aniline (or a phenol) is readily oxidized
to a radical cation through loss of an electron at the aro-
matic ring [43] and forms two possible reactive interme-
diates. A protein-associated sulfhydryl radical then
attacks the aromatic of the radical cation to form a cova-
lent bond at the orth- or para-position. Or, the reactive
intermediates bind to nucleophilic moieties on proteins
through the Michael addition. The second pathway cor-
responds to what Lepoittevin defined as a direct hapte-
nation route [44], whereby attack of a protein associated
sulfhydryl radical on the ring gives an intermediate rad-
ical (Scheme 1b).
A compound with lower energy of HOMO appears ei-
ther more stable or less reactive when reacting with a
protein associated sulfhydryl radical [24]. Therefore, as
shown in Figure 3, the sensitizers e.g., the aniline (CAS:
62-53-3) and the eugenol (CAS: 97-53-0) equipped
with higher ϵHOMO values can lose electron(s) more
easily to form radical cation intermediates than non-
sensitizers (e.g., 2-fluoro-5-nitroaniline (CAS: 369-36-
8), 4-aminobenzoic acid (CAS: 150-13-0), salicylic acid
(CAS: 69-72-7), and 3-hydroxy-4-nitrobenzoic acid (CAS:
619-14-7)). We noted that the non-sensitizers of anilines
and phenols are those that have the electron withdrawing
groups attached to the aromatic ring, such as –F, −NO2,
−COOH. This implies that introduction of electron with-
drawing groups to the aromatic ring of anilines or phenols













Free radical binding mechanism
Pro-Michael addition mechanism
 The pro-oxidation mechanism









Scheme 1 Reaction mechanisms of anilines binding to protein. (a) The pro-oxidation mechanism. (b) The direct reaction mechanism.
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approved drugs with aniline and phenol groups
There are no effective tools to predict the skin sensitiza-
tion potential of drugs, because drug-induced skin reac-
tions may be caused by several mechanisms either single
or mixed [27]. The skin sensitization, in the context, re-
fers to T-cell mediated sensitization (type IV allergy).
The reaction of chemicals with proteins was recognized
as one of the necessary process of the T-cell mediated















Figure 3 The structures, energies and shapes of HOMO, and charge d
aniline, 4-aminobenzoic acid, and 2-fluoro-5-nitroaniline); Phenols (right col
unit of the energy is hartree.offer valuable insights into better understanding the ini-
tiation of drug induced allergies.
We collected 53 drugs containing aniline and/or phe-
nol moieties from the DrugBank database. The informa-
tion of these 53 compounds is also available in the
Additional file 1. These FDA approved drugs were then
analyzed to filter out those with structural alerts of skin
sensitization. The sulfonamide drugs were also removed
due to they have different mechanisms of action. For ex-













ensity of representative anilines and phenols. Anilines (left column:
umn: eugenol, salicylic acid, and 3-hydroxy-4-nitrobenzoic acid). The
Table 2 Prediction of skin sensitization potential for 6 FDA approved drugs that have side effect of allergic dermatitis
reported in MetaADEDB database
DrugBank ID Name P Predictiona MetaADEDBb
1 DB00279 Liothyronine −0.001 N Y
2 DB01407 Clenbuterol 0.589 Y Y
3 DB00250 Dapsone 0.700 Y Y
4 DB00295 Morphine 0.580 Y Y
5 DB00327 Hydromorphone 0.595 Y Y
6 DB00481 Raloxifene 0.977 Y Y
aA drug is predicted as an sensitizer if its P value is greater than 0.50; Otherwise, as a non-sensitizer. bCompounds having the keywords “allergic dermatitis” in their
side effect reports in the MetaADEDB database are indicated as sensitizers. Y: Sensitizer; N: Non-sensitizer.
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quently form a reactive nitroso intermediate by auto-
oxidation that enables it to react with skin proteins [45].
Finally, twenty six compounds were obtained and their
skin sensitization potential was predicted by our model.
Among these 26 compounds, six of them were reported
to be able to induce “allergic dermatitis” according to
the side effect information in MetaADEDB database
(Table 2). Interestingly, our results showed that five of
them, e.g. Clenbuterol, Dapsone, Morphine, Hydromor-
phone and Raloxifene were correctly predicted as sensi-
tizers (Table 2) as their P values are greater than the
threshold 0.50. In addition, allergic dermatitis is a rare
side effect of Liothyronine according to the information
from https://www.universaldrugstore.com/medications/
Liothyronine/side-effects. However, users should be cau-
tious that there is no label for drugs not causing “allergic
dermatitis”, thus it is hard to find a negative set in FDA
approved drugs to further evaluate our model.
Conclusion
This study has demonstrated how quantum chemical
calculations can be utilized to predict skin sensitization
potential and to infer the reaction mechanism for a class
of mechanistically hard-to-be-classified chemicals con-
taining aniline and phenol moieties. The outcomes em-
phasized that the energy of highest occupied molecular
orbital plays an important role for predicting skin
sensitization potential of these compounds, indicating
the activation process occurred via either autoxidation
or direct reaction with free radical. Our model was fur-
ther applied to predict the allergenic potential of the ap-
proved drugs containing aniline and/or phenol moieties.
Several of these drugs were identified as sensitizers and
the prediction agreed well with their “allergic dermatitis”
side effect. Thus, the data indicate that our newly devel-
oped in silico algorithm shows promise as a preclinical
risk assessment tool for screening allergenic potential.
Again, we should point out that skin allergic reactions
are not commonly seen for drugs given via the oralroute. Though they may share similar mechanisms, cau-
tion should be taken when extrapolating our model from
skin sensitization potential for topically applied chemi-
cals to predict “allergic potential” of drugs.Additional file
Additional file 1: Predicted values and experimental data of
reported chemicals and FDA approved drugs that contain aniline
and/or phenol moieties.
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